Article Versions Notes

Figueiredo DBd, Kaneko K, Rodrigues TdC, MacLoughlin R, Miyaji EN, Saleem I, Gonçalves VM. Pneumococcal Surface Protein A-Hybrid Nanoparticles Protect Mice from Lethal Challenge after Mucosal Immunization Targeting the Lungs. Pharmaceutics. 2022; 14(6):1238. https://doi.org/10.3390/pharmaceutics14061238

Figueiredo, Douglas Borges de, Kan Kaneko, Tasson da Costa Rodrigues, Ronan MacLoughlin, Eliane Namie Miyaji, Imran Saleem, and Viviane Maimoni Gonçalves. 2022. "Pneumococcal Surface Protein A-Hybrid Nanoparticles Protect Mice from Lethal Challenge after Mucosal Immunization Targeting the Lungs" Pharmaceutics 14, no. 6: 1238. https://doi.org/10.3390/pharmaceutics14061238

Figueiredo, D. B. d., Kaneko, K., Rodrigues, T. d. C., MacLoughlin, R., Miyaji, E. N., Saleem, I., & Gonçalves, V. M. (2022). Pneumococcal Surface Protein A-Hybrid Nanoparticles Protect Mice from Lethal Challenge after Mucosal Immunization Targeting the Lungs. Pharmaceutics, 14(6), 1238. https://doi.org/10.3390/pharmaceutics14061238